MetaCap

Agape ATP (ATPC) vs LifeMD (LFMD)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.

Summary

LifeMD is the larger company by market cap ($134.6 million vs $2.0 million), about 66.3 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Head-to-head

ATPC versus LFMD key metrics
MetricATPCLFMD
Share price$2.03$2.79
Market cap$2.03M$134.63M
1-day change-2.40%+2.20%
YTD return—-18.18%
1-year return—-57.92%
5-year return—-46.14%
Forward P/E—7.34
EPS (TTM)$-1.04$-0.51
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$73.50$6.69
52-week low$1.72$2.56
Distance from 52-week high-97.24%-58.30%
Average volume843.03K841.67K
Shares outstanding1.00M48.26M
SectorHealth CareHealth Care
IndustryMedical/Nursing ServicesMedical/Nursing Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • LifeMD is about 66.3 times larger than Agape ATP by market value ($134.63M vs $2.03M).

ATPC vs LFMD FAQ

Which is bigger, Agape ATP or LifeMD?

LifeMD (LFMD) is larger, with a market capitalization of $134.63M compared with $2.03M for Agape ATP (ATPC).

Are Agape ATP and LifeMD in the same industry?

Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.

More comparisons